Wells Fargo Cuts PT on Nurix Therapeutics (NRIX) to $28 From $29

Nurix Therapeutics, Inc. (NASDAQ:NRIX) is one of the best low priced biotech stocks to invest in. Wells Fargo cut the price target on Nurix Therapeutics, Inc. (NASDAQ:NRIX) to $28 from $29 on April 9, ...

Ascentage Pharma to Present Four Promising Preclinical Studies Demonstrating the Potential of Combination Therapies at American Association for Cancer Research (A…

Olverembatinib, an investigational multikinase inhibitor (approved in China for CML), inhibits Src-family kinases (e.g., Lyn, ...

Eli Lilly (LLY) Says FDA Requests Additional Data on Obesity Pill

Eli Lilly and Company (NYSE:LLY) is one of the 10 Best Stocks to Buy for the Next Decade. On April 15, 2026, Eli Lilly and ...

After long fight, Idaho Downwinders stricken by cancer can get compensation

Mary Alice Glen was 37 years old when she was diagnosed with breast cancer in 1996. Years earlier, her mother died from ...

Eli Lilly's Stock Hinges on Earnings and Regulatory Crossroads

Eli Lilly & Co. enters a pivotal week, with its first-quarter earnings report on April 30th set against a backdrop of significant clinical triumphs and lingering regulatory scrutiny. The ...